Terms: = Cervical cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
5 results:
1. mycn amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract] [Full Text] [Related]
2. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.
Saito T; Takahashi F; Katabuchi H;
J Obstet Gynaecol Res; 2017 Nov; 43(11):1667-1677. PubMed ID: 28892220
[TBL] [Abstract] [Full Text] [Related]
3. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract] [Full Text] [Related]
4. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract] [Full Text] [Related]
5. Association of n-myc amplification with neuroblastoma: the Australian and New Zealand experience.
Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
[TBL] [Abstract] [Full Text] [Related]
